Showing results (271-280 of 290) with videos related to
Sort By:
Pageof 29
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 30, 2013
Apolipoprotein A1 potentiates lipoxin A4 synthesis and recovery of allergen-induced disrupted tight junctions in the airway epitheliumS-W Park, E H Lee, E-J Lee, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 9, 2001
Intravascular ultrasound analysis of beta radiation therapy for diffuse in-stent restenosis to inhibit intimal hyperplasiaM K Hong, S W Park, D H Moon, et al.Diabetic Medicine : a Journal of the British Diabetic Association|February 16, 2012
Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetesW J Kim, C Y Park, S E Park, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 7, 2004
Insulin sensitivity in physically fit and unfit children of parents with Type 2 diabetesC W Ahn, Y D Song, J H Nam, et al.Zygote (Cambridge, England)|March 24, 2010
Establishment and characterization of embryonic stem-like cells from porcine somatic cell nuclear transfer blastocystsS Kim, J H Kim, E Lee, et al.The Journal of Hospital Infection|February 25, 2018
Active surveillance for carbapenem-resistant Enterobacteriaceae, vancomycin-resistant enterococci and toxigenic Clostridium difficile among patients transferred from long-term care facilities in KoreaJ-H Hwang, J S Park, E Lee, et al.Gene Therapy|May 26, 1999
Isolation of efficient antivirals: genetic suppressor elements against HIV-1S J Dunn, S W Park, V Sharma, et al.Diabetes, Obesity & Metabolism|January 11, 2016
Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trialS Hong, C-Y Park, K A Han, et al.Diabetes, Obesity & Metabolism|January 13, 2015
Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extensionS-M Jin, C-Y Park, Y M Cho, et al.Diabetes Research and Clinical Practice|March 1, 1996
Role of HLA class II alleles in Korean patients with IDDMH C Lee, H Ikegami, T Fujisawa, et al.Pageof 29